Headwinds continue to impede cultivated meat development – Image for illustrative purposes only (Image credits: Unsplash)
The cultivated meat sector navigated a turbulent year in 2025, marked by federal budget reductions and a wave of state-level restrictions. Companies developing lab-grown proteins saw their numbers dwindle amid shrinking investments and policy barriers. A new industry report highlighted these pressures while noting isolated breakthroughs in production and retail trials.[1]
Federal Research Dollars Dry Up
The United States implemented a $2 million reduction across all federal research funding dedicated to cultivated meat development. National Science Foundation grants for the field also dropped by 25 percent. These cuts signaled broader fiscal constraints on innovative food technologies.[1]
Researchers and startups relied on such support to advance cell cultivation techniques and scale production. The funding shortfall threatened to cede U.S. leadership in the space. Projections indicated China would surpass the United States as the top financier of cultivated meat research and development in 2026, following Beijing’s $555 million infusion into biomanufacturing infrastructure in May 2025.[1]
Private capital offered limited relief. Cultivated meat firms raised $73.9 million in 2025, a sharp decline from $144 million the prior year. Investments trended smaller, with standout rounds including $29 million for Aleph Farms, $17.6 million for Mosa Meat, and $11 million for BlueNalu.[1]
State Legislatures Impose Sales Restrictions
Seven states enacted measures curbing cultivated meat by the close of 2025. Indiana and Texas introduced two-year moratoriums on sales, while Mississippi, Montana, and Nebraska prohibited them outright. These actions reflected concerns from traditional agriculture stakeholders over market competition and labeling.[1]
Legal challenges emerged quickly. The Institute for Justice filed suits against Florida’s ban and Texas’ moratorium. Upside Foods founder Uma Valeti emphasized consumer choice in response to Florida’s policy: “Anyone who wants to try cultivated meat should have the opportunity to do so. Our mission is to offer a delicious, safe, and ethical alternative to conventional meat, and we believe Floridians deserve the freedom to make their own food choices.”[1]
States with Cultivated Meat Restrictions (End of 2025)
- Indiana: Two-year moratorium
- Texas: Two-year moratorium
- Mississippi: Full ban
- Montana: Full ban
- Nebraska: Full ban
- Florida: Full ban
- Others totaling seven
Company Count Declines as Mergers Reshape Field
The roster of active cultivated meat companies shrank to 140 in 2025 from 155 in 2024. Shutdowns played a role, but consolidations dominated. Nexture Bio acquired Matrix F.T., Gourmey and Vital Meat combined into Parima, and Fork & Good took over Orbillion Bio.[1]
These shifts underscored cash flow strains and the high costs of scaling bioreactors and growth media. California bucked the national trend with targeted investments. The state allocated about $1 million each to a University of California facility in Davis for cultivated meat research and the Integrative Center for Alternative Meat and Protein.[1]
Progress Persists Amid Global Shifts
U.S. firms notched modest wins. Mission Barns introduced cultivated pork meatballs to Berkeley Bowl stores in San Francisco, enabling real-world consumer testing. Tufts University economist Sean Cash noted: “This partnership gives us a unique opportunity to study how consumers encounter cultivated meat outside the R&D lab or focus group setting.” Wildtype also served cell-cultured salmon at a domestic restaurant.[1]
Overseas momentum accelerated. Vow scaled to a 20,000-liter facility in Sydney, Australia. China opened its largest pilot plant with a 2,000-liter bioreactor, and plans advanced for facilities in India and the Asia Pacific via Hoxton Farms and Mitsui Chemicals. GEA invested $20 million in a Wisconsin center for alternative proteins, including cell cultivation.[1]
Consumer awareness remained low, with fewer than half familiar with cultivated meat. Terms like “lab-grown” registered most strongly, though education on its animal-free process boosted interest. The sector’s trajectory hinges on navigating policy hurdles and securing stable financing.
